Lockheed Martin (LMT) Q1 2026 Earnings Transcript

Lockheed Martin reported Q1 revenue of $18 billion, flat year over year despite a shortened fiscal period, with EPS of $6.44 down 12% and free cash flow of negative $291 million due to working capital timing and an ERP upgrade. Offsetting the mixed quarter, the company reaffirmed 2026 guidance for mid-single-digit sales growth, $8.4 billion-$8.7 billion operating profit, and $6.5 billion-$6.8 billion free cash flow, while highlighting $7 billion of PAC-3 orders, a $1.5 billion Peru F-16 win, and continued production ramp investments. Management also raised the venture fund to $1 billion and emphasized strong defense demand, but segment profit declines in Aeronautics, Space, and RMS temper the otherwise constructive outlook.

Analysis

The real signal here is not the headline quarter; it is the contract architecture shift. By moving missile ramps onto long-duration, cash-flow-neutral frameworks with clawbacks and inflation escalators, management is effectively converting volume optionality into a lower-beta annuity with government-protected downside. That should compress near-term execution risk premium, but it also pulls forward supply-chain capex and working-capital needs, which means the earnings inflection may outrun the cash inflection by several quarters.

The second-order winner set is broader than LMT: solid-rocket-motor, seeker, electronics, and industrial capacity providers should see a multi-year demand wave as second/third sourcing becomes economically rational. That should disproportionately help LHX and, more selectively, GD and smaller subsystems vendors; the flip side is that BA/NOC-style platform primes without the same rate-reset leverage may look comparatively slower-growing. The hidden loser is any supplier unable to finance inventory and tooling fast enough — the company is explicitly using government financing to bridge that constraint, which reduces the bargaining power of private capital at the sub-tier level.

The contrarian takeaway is that the market may be underestimating how much of this is already de-risked. The guidance hold despite a weak cash quarter suggests the operating issue is timing, not demand, and the defended cash profile into 2H creates a setup for multiple expansion if there is no fresh classified-program charge. The key risk is not budget demand; it is whether accelerated production can actually scale on schedule over the next 12-24 months without another rework event in Aeronautics or a supplier bottleneck in SRMs/seekers that forces incremental capex before volume arrives.

Key Decisions for Investors

• Long LMT vs NOC on a 3-6 month horizon: LMT has the cleaner near-term catalyst stack from missile ramp + contract structure, while NOC lacks an equivalent cash-flow acceleration narrative; target 8-12% relative outperformance, stop if LMT loses hold of guidance or takes a fresh program charge.
• Add LHX on weakness over the next 1-2 quarters: LMT’s ramp implies rising demand for seeker/electronic content and integration services; use LMT strength as a read-through for sub-tier content growth, with 10-15% upside if the munitions ramp stays on schedule.
• Pair long LMT / short BA for the next 6 months: LMT has government-backed production expansion and backlog conversion, while BA remains more exposed to execution resets and less protected on working-capital timing; this is a quality-of-cash-flow spread trade.
• Buy LMT Jan-2027 call spreads on any post-earnings pullback: the thesis is not Q2 beat/raise, but margin recovery plus cash normalization into 2H and 2027 as ramps mature; structure for 2-3x on successful de-risking with limited theta bleed.
• Monitor GD as a second-order beneficiary rather than an outright long here: if solid-rocket-motor expansion and joint capacity funding continue, GD could benefit, but execution is still contingent on LMT’s demand realization; better expressed as a relative long only after sub-tier capex evidence appears.